8gpk
From Proteopedia
(Difference between revisions)
Line 7: | Line 7: | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=8gpk FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=8gpk OCA], [https://pdbe.org/8gpk PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=8gpk RCSB], [https://www.ebi.ac.uk/pdbsum/8gpk PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=8gpk ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=8gpk FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=8gpk OCA], [https://pdbe.org/8gpk PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=8gpk RCSB], [https://www.ebi.ac.uk/pdbsum/8gpk PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=8gpk ProSAT]</span></td></tr> | ||
</table> | </table> | ||
+ | <div style="background-color:#fffaf0;"> | ||
+ | == Publication Abstract from PubMed == | ||
+ | Structure-guided immunofocusing HIV-1 vaccine design entails a comprehensive understanding of Envs from diverse HIV-1 subtypes, including circulating recombinant forms (CRFs). Here, we present the cryo-EM structures of Envs from two Asia prevalent CRFs (CRF01_AE and CRF07_BC) at 3.0 and 3.5 A. We compare the structures and glycosylation patterns of Envs from different subtypes and perform cross-clade statistical analyses to reveal the unique features of CRF01_AE V1 region, which are associated with the resistance to certain bNAbs. We also solve a 4.1 A cryo-EM structure of CRF01_AE Env in complex with F6, the first bNAb from CRF01_AE-infected individuals. F6 recognizes a gp120-gp41 spanning epitope to allosterically destabilize the Env trimer apex and weaken inter-protomer packing, which in turn hinders the receptor binding and induces Env trimer disassembly, demonstrating a dual mechanism of neutralization. These findings broaden our understanding of CRF Envs and shed lights on immunofocusing HIV-1 vaccine design. | ||
+ | |||
+ | Structures and immune recognition of Env trimers from two Asia prevalent HIV-1 CRFs.,Niu J, Wang Q, Zhao W, Meng B, Xu Y, Zhang X, Feng Y, Qi Q, Hao Y, Zhang X, Liu Y, Xiang J, Shao Y, Yang B Nat Commun. 2023 Aug 4;14(1):4676. doi: 10.1038/s41467-023-40321-x. PMID:37542068<ref>PMID:37542068</ref> | ||
+ | |||
+ | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
+ | </div> | ||
+ | <div class="pdbe-citations 8gpk" style="background-color:#fffaf0;"></div> | ||
+ | == References == | ||
+ | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> |
Current revision
Crystal structure of human anti-HIV-1 broadly neutralizing antibody F6 Fab
|